P/E společnosti Adma Biologics Inc
Jaká je hodnota metriky P/E společnosti Adma Biologics Inc?
Hodnota metriky P/E společnosti Adma Biologics Inc je 112.73
Jaká je definice metriky P/E?
P/E ratio je koeficient daný poměrem ceny akcie a příjmu společnosti na akcii za posledních 12 měsíců.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Adma Biologics Inc
Čemu se věnuje společnost Adma Biologics Inc?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Firmy s metrikou p/e podobnou společnosti Adma Biologics Inc
- Hodnota metriky P/E společnosti Downing Four VCT DP67 je 112.50
- Hodnota metriky P/E společnosti Solitaire Machine Tools je 112.51
- Hodnota metriky P/E společnosti Ravindra je 112.54
- Hodnota metriky P/E společnosti Hooker Furnishings je 112.64
- Hodnota metriky P/E společnosti ELGI Equipments je 112.71
- Hodnota metriky P/E společnosti JSW je 112.73
- Hodnota metriky P/E společnosti Adma Biologics Inc je 112.73
- Hodnota metriky P/E společnosti Guangshen Railway je 112.76
- Hodnota metriky P/E společnosti Himadri Speciality Chemical je 112.80
- Hodnota metriky P/E společnosti Goenka Business & Finance je 112.82
- Hodnota metriky P/E společnosti Roots je 112.90
- Hodnota metriky P/E společnosti Oriental Hotels je 112.90
- Hodnota metriky P/E společnosti Lilly(Eli) & Co je 112.99